4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-013887
Options or other derivatives
- Executive Vice President & CFO acquired 145,244 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Konidaris Tasos Executive Vice President & CFO | 2026-03-02 | Grant or award · Restricted Stock Units | +72,622 | 72,622 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2026-03-02 | Grant or award · Performance-Based Restricted Stock Units | +72,622 | 72,622 | D | ||
Loading xslF345X05/wk-form4_1772573278.xml…